Home LiteratureArticle Details
PMID: 23689369 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

The lectin domain of the polypeptide GalNAc transferase family of glycosyltransferases (ppGalNAc Ts) acts as a switch directing glycopeptide substrate glycosylation in an N- or C-terminal direction, further controlling mucin type O-glycosylation.

The Journal of biological chemistry ·Vol. 288 ·No. 27 ·2013-07-05 ·Pages 19900-14

Gerken TA, Revoredo L, Thome JJ, Tabak LA, Vester-Christensen MB, Clausen H, Gahlay GK, Jarvis DL, Johnson RW, Moniz HA, Moremen K

Abstract

Mucin type O-glycosylation is initiated by a large family of polypeptide GalNAc transferases (ppGalNAc Ts) that add α-GalNAc to the Ser and Thr residues of peptides. Of the 20 human isoforms, all but one are composed of two globular domains linked by a short flexible linker: a catalytic domain and a ricin-like lectin carbohydrate binding domain. Presently, the roles of the catalytic and lectin domains in peptide and glycopeptide recognition and specificity remain unclear. To systematically study the role of the lectin domain in ppGalNAc T glycopeptide substrate utilization, we have developed a series of novel random glycopeptide substrates containing a single GalNAc-O-Thr residue placed near either the N or C terminus of the glycopeptide substrate. Our results reveal that the presence and N- or C-terminal placement of the GalNAc-O-Thr can be important determinants of overall catalytic activity and specificity that differ between transferase isoforms. For example, ppGalNAc T1, T2, and T14 prefer C-terminally placed GalNAc-O-Thr, whereas ppGalNAc T3 and T6 prefer N-terminally placed GalNAc-O-Thr. Several transferase isoforms, ppGalNAc T5, T13, and T16, display equally enhanced N- or C-terminal activities relative to the nonglycosylated control peptides. This N- and/or C-terminal selectivity is presumably due to weak glycopeptide binding to the lectin domain, whose orientation relative to the catalytic domain is dynamic and isoform-dependent. Such N- or C-terminal glycopeptide selectivity provides an additional level of control or fidelity for the O-glycosylation of biologically significant sites and suggests that O-glycosylation may in some instances be exquisitely controlled.

Keywords
Control of Glycosylation Convertases Edman Sequencing Glycobiology Glycoprotein Biosynthesis Glycosyltransferases Lectin Mucins O-Glycosylation Random Glycopeptide
MeSH Terms
Catalysis Glycopeptides/chemistry,genetics,metabolism Glycosylation Humans Isoenzymes/chemistry,genetics,metabolism Lectins N-Acetylgalactosaminyltransferases/chemistry,genetics,metabolism Protein Structure, Tertiary Substrate Specificity/physiology
Chemicals
Glycopeptides Isoenzymes Lectins N-Acetylgalactosaminyltransferases polypeptide N-acetylgalactosaminyltransferase
Authors & Affiliations
11 authors, click to expand affiliations / ORCID
Gerken Thomas A
Department of Pediatrics, WA Bernbaum Center for Cystic Fibrosis Research, Case Western Reserve University, Cleveland, Ohio 44106, USA.
Revoredo Leslie
Thome Joseph J C
Tabak Lawrence A
Vester-Christensen Malene Bech
Clausen Henrik
Gahlay Gagandeep K
Jarvis Donald L
Johnson Roy W
Moniz Heather A
Moremen Kelley
References (75)
75 references, click to expand
  1. Role of peptide sequence and neighboring residue glycosylation on the substrate specificity of the uridine 5'-diphosphate-alpha-N-acetylgalactosamine:polypeptide N-acetylgalactosaminyl transferases T1 and T2: kinetic modeling of the porcine and canine submaxillary gland mucin tandem repeats.
    Biochemistry. 2004 Aug 3;43(30):9888-900 PMID: 15274643
  2. Identification of common and unique peptide substrate preferences for the UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferases T1 and T2 derived from oriented random peptide substrates.
    J Biol Chem. 2006 Oct 27;281(43):32403-16 PMID: 16912039
  3. Mucins in cancer: protection and control of the cell surface.
    Nat Rev Cancer. 2004 Jan;4(1):45-60 PMID: 14681689
  4. O-glycosylation of mucin-like domain retains the neutral ceramidase on the plasma membranes as a type II integral membrane protein.
    J Biol Chem. 2003 Mar 21;278(12):10523-30 PMID: 12499379
  5. Crystal structure of Streptomyces olivaceoviridis E-86 beta-xylanase containing xylan-binding domain.
    J Mol Biol. 2000 Jul 14;300(3):575-85 PMID: 10884353
  6. Role of N- and O-glycans in polarized biosynthetic sorting.
    Am J Physiol Cell Physiol. 2006 Jan;290(1):C1-C10 PMID: 16338974
  7. Regulation of TGF-(beta) signalling by N-acetylgalactosaminyltransferase-like 1.
    Development. 2008 May;135(10):1813-22 PMID: 18417620
  8. Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology.
    EMBO J. 2013 May 15;32(10):1478-88 PMID: 23584533
  9. A systematic study of site-specific GalNAc-type O-glycosylation modulating proprotein convertase processing.
    J Biol Chem. 2011 Nov 18;286(46):40122-32 PMID: 21937429
  10. The role of mucin-type O-glycans in eukaryotic development.
    Semin Cell Dev Biol. 2010 Aug;21(6):616-21 PMID: 20144722
  11. Emerging paradigms for the initiation of mucin-type protein O-glycosylation by the polypeptide GalNAc transferase family of glycosyltransferases.
    J Biol Chem. 2011 Apr 22;286(16):14493-507 PMID: 21349845
  12. How nature can exploit nonspecific catalytic and carbohydrate binding modules to create enzymatic specificity.
    Proc Natl Acad Sci U S A. 2012 Dec 18;109(51):20889-94 PMID: 23213210
  13. Post-translational modifications of recombinant P-selectin glycoprotein ligand-1 required for binding to P- and E-selectin.
    J Biol Chem. 1996 Feb 9;271(6):3255-64 PMID: 8621728
  14. Recent insights into the biological roles of mucin-type O-glycosylation.
    Glycoconj J. 2009 Apr;26(3):325-34 PMID: 18695988
  15. Defective angiogenesis and fatal embryonic hemorrhage in mice lacking core 1-derived O-glycans.
    J Cell Biol. 2004 Feb 2;164(3):451-9 PMID: 14745002
  16. The lectin domain of UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-T4 directs its glycopeptide specificities.
    J Biol Chem. 2000 Dec 8;275(49):38197-205 PMID: 10984485
  17. O-glycosylation modulates proprotein convertase activation of angiopoietin-like protein 3: possible role of polypeptide GalNAc-transferase-2 in regulation of concentrations of plasma lipids.
    J Biol Chem. 2010 Nov 19;285(47):36293-303 PMID: 20837471
  18. The lectin domains of polypeptide GalNAc-transferases exhibit carbohydrate-binding specificity for GalNAc: lectin binding to GalNAc-glycopeptide substrates is required for high density GalNAc-O-glycosylation.
    Glycobiology. 2007 Apr;17(4):374-87 PMID: 17215257
  19. Core-glycosylated mucin-like repeats from MUC1 are an apical targeting signal.
    J Biol Chem. 2011 Nov 11;286(45):39072-81 PMID: 21937430
  20. O-glycosylation modulates integrin and FGF signalling by influencing the secretion of basement membrane components.
    Nat Commun. 2012 May 29;3:869 PMID: 22643896
  21. Carbohydrate-binding modules promote the enzymatic deconstruction of intact plant cell walls by targeting and proximity effects.
    Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15293-8 PMID: 20696902
  22. A direct interaction between EXT proteins and glycosyltransferases is defective in hereditary multiple exostoses.
    Hum Mol Genet. 1999 Nov;8(12):2155-64 PMID: 10545594
  23. Ablation of the Galnt3 gene leads to low-circulating intact fibroblast growth factor 23 (Fgf23) concentrations and hyperphosphatemia despite increased Fgf23 expression.
    Endocrinology. 2009 Jun;150(6):2543-50 PMID: 19213845
  24. Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions.
    EMBO Rep. 2006 Jun;7(6):599-604 PMID: 16741504
  25. The (QxW)3 domain: a flexible lectin scaffold.
    Protein Sci. 1996 Aug;5(8):1490-501 PMID: 8844840
  26. Location, location, location: new insights into O-GalNAc protein glycosylation.
    Trends Cell Biol. 2011 Mar;21(3):149-58 PMID: 21145746
  27. Expression of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase isoforms in murine tissues determined by real-time PCR: a new view of a large family.
    Glycobiology. 2003 Jul;13(7):549-57 PMID: 12651884
  28. Function of the lectin domain of polypeptide N-acetylgalactosaminyltransferase 1.
    Biochem Biophys Res Commun. 2002 Nov 15;298(5):755-9 PMID: 12419318
  29. Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family.
    Glycobiology. 2012 Jun;22(6):736-56 PMID: 22183981
  30. Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers.
    Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12921-5 PMID: 19617566
  31. Cloning and characterization of a new human UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase, designated pp-GalNAc-T13, that is specifically expressed in neurons and synthesizes GalNAc alpha-serine/threonine antigen.
    J Biol Chem. 2003 Jan 3;278(1):573-84 PMID: 12407114
  32. Site-specific protein O-glycosylation modulates proprotein processing - deciphering specific functions of the large polypeptide GalNAc-transferase gene family.
    Biochim Biophys Acta. 2012 Dec;1820(12):2079-94 PMID: 23022508
  33. miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis.
    Cancer Cell. 2011 Jul 12;20(1):104-18 PMID: 21741600
  34. Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL.
    Nat Med. 2007 Sep;13(9):1070-7 PMID: 17767167
  35. Concerted evolution within the Drosophila dumpy gene.
    Genetics. 2007 May;176(1):309-25 PMID: 17237523
  36. A putative polypeptide N-acetylgalactosaminyltransferase/Williams-Beuren syndrome chromosome region 17 (WBSCR17) regulates lamellipodium formation and macropinocytosis.
    J Biol Chem. 2012 Sep 14;287(38):32222-35 PMID: 22787146
  37. GALNT9 gene expression is a prognostic marker in neuroblastoma patients.
    Clin Chem. 2013 Jan;59(1):225-33 PMID: 23136245
  38. UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferases: completion of the family tree.
    Glycobiology. 2012 Jun;22(6):768-77 PMID: 22186971
  39. Lectin domains of polypeptide GalNAc transferases exhibit glycopeptide binding specificity.
    J Biol Chem. 2011 Sep 16;286(37):32684-96 PMID: 21768105
  40. NMR characterization of immunoglobulin G Fc glycan motion on enzymatic sialylation.
    Biochemistry. 2012 Jun 5;51(22):4618-26 PMID: 22574931
  41. Elucidation of the sugar recognition ability of the lectin domain of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3 by using unnatural glycopeptide substrates.
    Glycobiology. 2012 Mar;22(3):429-38 PMID: 22042768
  42. Structural basis of carbohydrate transfer activity by human UDP-GalNAc: polypeptide alpha-N-acetylgalactosaminyltransferase (pp-GalNAc-T10).
    J Mol Biol. 2006 Jun 9;359(3):708-27 PMID: 16650853
  43. Multiple members of the UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase family are essential for viability in Drosophila.
    J Biol Chem. 2012 Feb 17;287(8):5243-52 PMID: 22157008
  44. Biological, clinical and population relevance of 95 loci for blood lipids.
    Nature. 2010 Aug 5;466(7307):707-13 PMID: 20686565
  45. Fold recognition and molecular modeling of a lectin-like domain in UDP-GalNac:polypeptide N-acetylgalactosaminyltransferases.
    Protein Eng. 1997 Dec;10(12):1353-6 PMID: 9542995
  46. UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 as a new immunohistochemical breast cancer marker.
    J Histochem Cytochem. 2006 Mar;54(3):317-28 PMID: 16260590
  47. The lectin domain of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1 is involved in O-glycosylation of a polypeptide with multiple acceptor sites.
    J Biol Chem. 2002 Dec 6;277(49):47088-96 PMID: 12364335
  48. Mucin-type O-glycosylation during development.
    J Biol Chem. 2013 Mar 8;288(10):6921-9 PMID: 23329828
  49. Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation.
    J Biol Chem. 2006 Jul 7;281(27):18370-7 PMID: 16638743
  50. O-linked glycans mediate apical sorting of human intestinal sucrase-isomaltase through association with lipid rafts.
    Curr Biol. 1999 Jun 3;9(11):593-6 PMID: 10359703
  51. Evidence for glycosylation-dependent activities of polypeptide N-acetylgalactosaminyltransferases rGalNAc-T2 and -T4 on mucin glycopeptides.
    Glycobiology. 2001 Sep;11(9):731-40 PMID: 11555617
  52. Mechanisms in protein O-glycan biosynthesis and clinical and molecular aspects of protein O-glycan biosynthesis defects: a review.
    Clin Chem. 2006 Apr;52(4):574-600 PMID: 16497938
  53. Structural basis for sugar recognition, including the Tn carcinoma antigen, by the lectin SNA-II from Sambucus nigra.
    Proteins. 2009 Apr;75(1):89-103 PMID: 18798567
  54. Carbohydrate-binding modules: fine-tuning polysaccharide recognition.
    Biochem J. 2004 Sep 15;382(Pt 3):769-81 PMID: 15214846
  55. Polypeptide N-acetylgalactosaminyltransferase 6 disrupts mammary acinar morphogenesis through O-glycosylation of fibronectin.
    Neoplasia. 2011 Apr;13(4):320-6 PMID: 21472136
  56. Dynamic association between the catalytic and lectin domains of human UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferase-2.
    J Biol Chem. 2006 Mar 31;281(13):8613-9 PMID: 16434399
  57. Heterozygosity for a loss-of-function mutation in GALNT2 improves plasma triglyceride clearance in man.
    Cell Metab. 2011 Dec 7;14(6):811-8 PMID: 22152306
  58. The catalytic and lectin domains of UDP-GalNAc:polypeptide alpha-N-Acetylgalactosaminyltransferase function in concert to direct glycosylation site selection.
    J Biol Chem. 2008 Aug 22;283(34):22942-51 PMID: 18562306
  59. Glycopeptide-preferring polypeptide GalNAc transferase 10 (ppGalNAc T10), involved in mucin-type O-glycosylation, has a unique GalNAc-O-Ser/Thr-binding site in its catalytic domain not found in ppGalNAc T1 or T2.
    J Biol Chem. 2009 Jul 24;284(30):20387-97 PMID: 19460755
  60. Enhanced mass spectrometric mapping of the human GalNAc-type O-glycoproteome with SimpleCells.
    Mol Cell Proteomics. 2013 Apr;12(4):932-44 PMID: 23399548
  61. A novel human UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase, GalNAc-T7, with specificity for partial GalNAc-glycosylated acceptor substrates.
    FEBS Lett. 1999 Oct 29;460(2):226-30 PMID: 10544240
  62. Probing isoform-specific functions of polypeptide GalNAc-transferases using zinc finger nuclease glycoengineered SimpleCells.
    Proc Natl Acad Sci U S A. 2012 Jun 19;109(25):9893-8 PMID: 22566642
  63. Glycobiology on the fly: developmental and mechanistic insights from Drosophila.
    Glycobiology. 2009 Feb;19(2):102-11 PMID: 18824561
  64. Determination of the site-specific oligosaccharide distribution of the O-glycans attached to the porcine submaxillary mucin tandem repeat. Further evidence for the modulation of O-glycans side chain structures by peptide sequence.
    J Biol Chem. 2002 Mar 8;277(10):7736-51 PMID: 11777921
  65. The beginnings of mucin biosynthesis: the crystal structure of UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferase-T1.
    Proc Natl Acad Sci U S A. 2004 Oct 26;101(43):15307-12 PMID: 15486088
  66. Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth.
    Oncogene. 2011 Dec 8;30(49):4843-54 PMID: 21625220
  67. Bifidobacterial α-galactosidase with unique carbohydrate-binding module specifically acts on blood group B antigen.
    Glycobiology. 2013 Feb;23(2):232-40 PMID: 23089618
  68. Core2 O-glycan structure is essential for the cell surface expression of sucrase isomaltase and dipeptidyl peptidase-IV during intestinal cell differentiation.
    J Biol Chem. 2010 Nov 26;285(48):37683-92 PMID: 20841351
  69. The role of mutant UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis.
    J Clin Endocrinol Metab. 2006 Oct;91(10):4037-42 PMID: 16868048
  70. Role of sialic acid on the viscosity of canine tracheal mucin glycoprotein.
    Biochem Biophys Res Commun. 1994 Nov 30;205(1):402-9 PMID: 7999055
  71. Cloning and characterization of a close homologue of human UDP-N-acetyl-alpha-D-galactosamine:Polypeptide N-acetylgalactosaminyltransferase-T3, designated GalNAc-T6. Evidence for genetic but not functional redundancy.
    J Biol Chem. 1999 Sep 3;274(36):25362-70 PMID: 10464263
  72. Mucin core O-glycosylation is modulated by neighboring residue glycosylation status. Kinetic modeling of the site-specific glycosylation of the apo-porcine submaxillary mucin tandem repeat by UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases T1 and T2.
    J Biol Chem. 2002 Dec 20;277(51):49850-62 PMID: 12397077
  73. Characterization of a novel human UDP-GalNAc transferase, pp-GalNAc-T10.
    FEBS Lett. 2002 Nov 6;531(2):115-21 PMID: 12417297
  74. Gel-forming mucins appeared early in metazoan evolution.
    Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16209-14 PMID: 17911254
  75. Conservation of peptide acceptor preferences between Drosophila and mammalian polypeptide-GalNAc transferase ortholog pairs.
    Glycobiology. 2008 Nov;18(11):861-70 PMID: 18669915
Article Info
Journal
The Journal of biological chemistry
Abbr.
J Biol Chem
ISSN
1083-351X
Published
2013-07-05
Epub
2013-00-20
Pages
19900-14
Language
English
Region
United States
NLM ID
2985121R
PMCID
PMC3707691
Subset
IM
Grants
NIGMS NIH HHS · P41-GM103390 · United States
NCI NIH HHS · R01 CA078834 · United States
NIDDK NIH HHS · P30 DK027651 · United States
NCRR NIH HHS · P41-RR005351 · United States
NIGMS NIH HHS · P41 GM103390 · United States
NCRR NIH HHS · P41 RR005351 · United States
Intramural NIH HHS · United States
NCI NIH HHS · R01-CA78834 · United States
NIGMS NIH HHS · U01 GM113534 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com